In today's edition of Market Checkup, health-care analysts David Williamson and Max Macaluso take a close look at Onyx Pharmaceuticals, which may or may not be acquired in the coming weeks, and Eli Lilly, which recently announced positive clinical trial results for an experimental cancer drug.
David Williamson owns shares of Pfizer. Max Macaluso, Ph.D. owns shares of Celgene. The Motley Fool recommends Celgene. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.